ELI LILLY & Co is 781.0x more valuable than ATAI Life Sciences N.V. by market capitalization ($1.072 T vs $1.37 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ATAI | LLY |
|---|---|---|
| Market cap | $1.37 B | $1.072 T |
| US-listed rank | #2397 | #10 |
| Revenue (latest FY) | $308.00K | $65.18B |
| Net income (latest FY) | -$149.27M | $20.64B |
| Net margin | -48464.0% | 31.7% |
| P/E (trailing FY) | - | 51.9 |
| SEC filings | 320 | 989 |
ELI LILLY & Co is 781.0x more valuable than ATAI Life Sciences N.V. by market capitalization ($1.072 T vs $1.37 B).
In their latest fiscal years, ATAI Life Sciences N.V. reported $308.00K in revenue while ELI LILLY & Co reported $65.18B.
Full pages: ATAI Life Sciences N.V. and ELI LILLY & Co, or browse the full rankings.